placental growth factor Search Results


93
Elabscience Biotechnology angiogenic factor plgf
Angiogenic Factor Plgf, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/Rat+PGF+(Placental+Growth+Factor)+ELISA+Kit/pm38001772-106-13-17
Average 93 stars, based on 1 article reviews
angiogenic factor plgf - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Proteintech anti pgf antibody
Anti Pgf Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/Placental+Growth+Factor+Antibody/pmc11610333-51-8-10
Average 93 stars, based on 1 article reviews
anti pgf antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

92
Elabscience Biotechnology elisa kit
HPS development <t>in</t> <t>Plgf</t> –/– rats after CBDL and PPVL surgery. (A) Experimental procedures. (B) Circulating PlGF levels in serum determined using <t>ELISA.</t> (C) Detection of Plgf mRNA levels in liver and lung using RT-qPCR. (D) A-aO 2 in arterial blood. (E) Quantification of contrast-enhanced transthoracic echocardiogram: ratio of the difference in acoustic signal between baseline and after injection in the left ventricle to the right ventricle. (F) Quantification of total microspheres in one kidney by fluorescence-activated cell sorting after jugular vein injection. Data are mean ± SEM; comparisons were made using one-way ANOVA followed by the Tukey test: n.s., not significant ( p >0.05); ∗ p <0.05, ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, vs. Sham WT group; &&& p <0.001, &&&& p <0.0001 vs. WT CBDL. A-aO 2 , alveolar–arterial oxygen gradient; CBDL, common bile duct ligation; HPS, hepatopulmonary syndrome; PIGF, placental growth factor; PPVL, partial portal vein ligation; real-time quantitative PCR (RT-qPCR); WT, wild-type.
Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/Rat+PGF+(Placental+Growth+Factor)+CLIA+Kit/pmc11840504-108-7-10
Average 92 stars, based on 1 article reviews
elisa kit - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

94
Rockland Immunochemicals koa0292
HPS development <t>in</t> <t>Plgf</t> –/– rats after CBDL and PPVL surgery. (A) Experimental procedures. (B) Circulating PlGF levels in serum determined using <t>ELISA.</t> (C) Detection of Plgf mRNA levels in liver and lung using RT-qPCR. (D) A-aO 2 in arterial blood. (E) Quantification of contrast-enhanced transthoracic echocardiogram: ratio of the difference in acoustic signal between baseline and after injection in the left ventricle to the right ventricle. (F) Quantification of total microspheres in one kidney by fluorescence-activated cell sorting after jugular vein injection. Data are mean ± SEM; comparisons were made using one-way ANOVA followed by the Tukey test: n.s., not significant ( p >0.05); ∗ p <0.05, ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, vs. Sham WT group; &&& p <0.001, &&&& p <0.0001 vs. WT CBDL. A-aO 2 , alveolar–arterial oxygen gradient; CBDL, common bile duct ligation; HPS, hepatopulmonary syndrome; PIGF, placental growth factor; PPVL, partial portal vein ligation; real-time quantitative PCR (RT-qPCR); WT, wild-type.
Koa0292, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/Human+PLGF+ELISA+Kit/10__1002_slash_btm2__70114-258-28-25
Average 94 stars, based on 1 article reviews
koa0292 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Elabscience Biotechnology human placental growth factor pgf elisa kit
HPS development <t>in</t> <t>Plgf</t> –/– rats after CBDL and PPVL surgery. (A) Experimental procedures. (B) Circulating PlGF levels in serum determined using <t>ELISA.</t> (C) Detection of Plgf mRNA levels in liver and lung using RT-qPCR. (D) A-aO 2 in arterial blood. (E) Quantification of contrast-enhanced transthoracic echocardiogram: ratio of the difference in acoustic signal between baseline and after injection in the left ventricle to the right ventricle. (F) Quantification of total microspheres in one kidney by fluorescence-activated cell sorting after jugular vein injection. Data are mean ± SEM; comparisons were made using one-way ANOVA followed by the Tukey test: n.s., not significant ( p >0.05); ∗ p <0.05, ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, vs. Sham WT group; &&& p <0.001, &&&& p <0.0001 vs. WT CBDL. A-aO 2 , alveolar–arterial oxygen gradient; CBDL, common bile duct ligation; HPS, hepatopulmonary syndrome; PIGF, placental growth factor; PPVL, partial portal vein ligation; real-time quantitative PCR (RT-qPCR); WT, wild-type.
Human Placental Growth Factor Pgf Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/Human+PGF+(Placental+Growth+Factor)+ELISA+Kit/10__21705_slash_mcbs__v8i3__465-43-55-62
Average 93 stars, based on 1 article reviews
human placental growth factor pgf elisa kit - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Boster Bio serum gdf 15
HPS development <t>in</t> <t>Plgf</t> –/– rats after CBDL and PPVL surgery. (A) Experimental procedures. (B) Circulating PlGF levels in serum determined using <t>ELISA.</t> (C) Detection of Plgf mRNA levels in liver and lung using RT-qPCR. (D) A-aO 2 in arterial blood. (E) Quantification of contrast-enhanced transthoracic echocardiogram: ratio of the difference in acoustic signal between baseline and after injection in the left ventricle to the right ventricle. (F) Quantification of total microspheres in one kidney by fluorescence-activated cell sorting after jugular vein injection. Data are mean ± SEM; comparisons were made using one-way ANOVA followed by the Tukey test: n.s., not significant ( p >0.05); ∗ p <0.05, ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, vs. Sham WT group; &&& p <0.001, &&&& p <0.0001 vs. WT CBDL. A-aO 2 , alveolar–arterial oxygen gradient; CBDL, common bile duct ligation; HPS, hepatopulmonary syndrome; PIGF, placental growth factor; PPVL, partial portal vein ligation; real-time quantitative PCR (RT-qPCR); WT, wild-type.
Serum Gdf 15, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/Human+GDF-15+Recombinant+Protein/10__2399_slash_raed__15__s02010216-4362-0-2
Average 93 stars, based on 1 article reviews
serum gdf 15 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Boster Bio nrg 1
HPS development <t>in</t> <t>Plgf</t> –/– rats after CBDL and PPVL surgery. (A) Experimental procedures. (B) Circulating PlGF levels in serum determined using <t>ELISA.</t> (C) Detection of Plgf mRNA levels in liver and lung using RT-qPCR. (D) A-aO 2 in arterial blood. (E) Quantification of contrast-enhanced transthoracic echocardiogram: ratio of the difference in acoustic signal between baseline and after injection in the left ventricle to the right ventricle. (F) Quantification of total microspheres in one kidney by fluorescence-activated cell sorting after jugular vein injection. Data are mean ± SEM; comparisons were made using one-way ANOVA followed by the Tukey test: n.s., not significant ( p >0.05); ∗ p <0.05, ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, vs. Sham WT group; &&& p <0.001, &&&& p <0.0001 vs. WT CBDL. A-aO 2 , alveolar–arterial oxygen gradient; CBDL, common bile duct ligation; HPS, hepatopulmonary syndrome; PIGF, placental growth factor; PPVL, partial portal vein ligation; real-time quantitative PCR (RT-qPCR); WT, wild-type.
Nrg 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/Anti-GDF15+Antibody/pmc04525875-94-2-3
Average 93 stars, based on 1 article reviews
nrg 1 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Shanghai Korain Biotech Co Ltd human mic 1 elisa kit
HPS development <t>in</t> <t>Plgf</t> –/– rats after CBDL and PPVL surgery. (A) Experimental procedures. (B) Circulating PlGF levels in serum determined using <t>ELISA.</t> (C) Detection of Plgf mRNA levels in liver and lung using RT-qPCR. (D) A-aO 2 in arterial blood. (E) Quantification of contrast-enhanced transthoracic echocardiogram: ratio of the difference in acoustic signal between baseline and after injection in the left ventricle to the right ventricle. (F) Quantification of total microspheres in one kidney by fluorescence-activated cell sorting after jugular vein injection. Data are mean ± SEM; comparisons were made using one-way ANOVA followed by the Tukey test: n.s., not significant ( p >0.05); ∗ p <0.05, ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, vs. Sham WT group; &&& p <0.001, &&&& p <0.0001 vs. WT CBDL. A-aO 2 , alveolar–arterial oxygen gradient; CBDL, common bile duct ligation; HPS, hepatopulmonary syndrome; PIGF, placental growth factor; PPVL, partial portal vein ligation; real-time quantitative PCR (RT-qPCR); WT, wild-type.
Human Mic 1 Elisa Kit, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/Human+Growth+Differentiation+Factor+15/pm40692366-91-9-13
Average 94 stars, based on 1 article reviews
human mic 1 elisa kit - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
Boster Bio spint2
Cellular origin of upregulated proteins. (A) Transcriptome analysis of the top 30 proteins increased in OC-plasma (from ). (B) Proteome analysis as in (A) . Due to the lower sensitivity of MS-based proteomics, especially for secreted proteins , data were not available for a number of proteins. Boxplots show medians (horizontal line in boxes), upper and lower quartiles (box) and range (whiskers). Arrows point out MUC16, <t>SPINT2,</t> and WFDC2. TU, tumor cells; TAM, tumor-associated macrophage; TAT, tumor-associated T-cells.
Spint2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/Human+HAI-2%2FSPINT2+ELISA+Kit+PicoKine/pmc06839336-89-72-74
Average 90 stars, based on 1 article reviews
spint2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Boster Bio protein igfbp1
Cellular origin of upregulated proteins. (A) Transcriptome analysis of the top 30 proteins increased in OC-plasma (from ). (B) Proteome analysis as in (A) . Due to the lower sensitivity of MS-based proteomics, especially for secreted proteins , data were not available for a number of proteins. Boxplots show medians (horizontal line in boxes), upper and lower quartiles (box) and range (whiskers). Arrows point out MUC16, <t>SPINT2,</t> and WFDC2. TU, tumor cells; TAM, tumor-associated macrophage; TAT, tumor-associated T-cells.
Protein Igfbp1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/Anti-IGFBP1+Antibody+Picoband/pm27364572-78-31-35
Average 90 stars, based on 1 article reviews
protein igfbp1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

91
Boster Bio human igfbp1 elisa kit
Figure 2 NR4A regulation of human endometrial stromal cell (hESC) decidualization in vitro. hESCs were transduced with Ad-LacZ or Ad-NR4A at a multiplicity of infection (MOI) of 25 or were treated with 0.5 mM 8-Br-cAMP and 1 µM MPA for 48 h. PRL (A) and <t>IGFBP1</t> (B) mRNA levels were measured by real-time PCR. The results are presented as the mean ± SEM; n = 3 samples. * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with Ad-LacZ. hESCs were infected with the indicated adenoviruses at a MOI of 50, followed by treatment with or without 8-Br-cAMP and MPA for an add- itional 4 days. Prolactin (C) and IGFBP-1 (D) released into the medium was measured by Enzyme Linked Fluorescent Assay (ELFA) and ELISA. The results are presented as the mean ± SEM; n = 5 samples. * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with Ad-LacZ. hESCs were transfected with 50 nM of the indicated specific NR4A siRNA for 72 h, followed by treatment with or without 8-Br-cAMP and MPA for an additional 4 days. Prolactin (E) and IGFBP-1 (F) released into the medium were measured by ELFA and ELISA. The results are presented as the mean ± SEM; n = 4 sam- ples. *** P < 0.001 compared with siCTL. # P < 0.05 and ## P < 0.01 compared with siCTL plus 8-Br-cAMP and MPA. (G and H) Fluorescein isothio- cyanate labeled phalloidin was used to label actin filaments, and immunofluorescence was used to analyze the morphological transformation of hESCs.
Human Igfbp1 Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/Human+IGFBP-1+ELISA+Kit+PicoKine/pm27515096-139-25-29
Average 91 stars, based on 1 article reviews
human igfbp1 elisa kit - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC plgf (placental growth factor)
Figure 2 NR4A regulation of human endometrial stromal cell (hESC) decidualization in vitro. hESCs were transduced with Ad-LacZ or Ad-NR4A at a multiplicity of infection (MOI) of 25 or were treated with 0.5 mM 8-Br-cAMP and 1 µM MPA for 48 h. PRL (A) and <t>IGFBP1</t> (B) mRNA levels were measured by real-time PCR. The results are presented as the mean ± SEM; n = 3 samples. * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with Ad-LacZ. hESCs were infected with the indicated adenoviruses at a MOI of 50, followed by treatment with or without 8-Br-cAMP and MPA for an add- itional 4 days. Prolactin (C) and IGFBP-1 (D) released into the medium was measured by Enzyme Linked Fluorescent Assay (ELFA) and ELISA. The results are presented as the mean ± SEM; n = 5 samples. * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with Ad-LacZ. hESCs were transfected with 50 nM of the indicated specific NR4A siRNA for 72 h, followed by treatment with or without 8-Br-cAMP and MPA for an additional 4 days. Prolactin (E) and IGFBP-1 (F) released into the medium were measured by ELFA and ELISA. The results are presented as the mean ± SEM; n = 4 sam- ples. *** P < 0.001 compared with siCTL. # P < 0.05 and ## P < 0.01 compared with siCTL plus 8-Br-cAMP and MPA. (G and H) Fluorescein isothio- cyanate labeled phalloidin was used to label actin filaments, and immunofluorescence was used to analyze the morphological transformation of hESCs.
Plgf (Placental Growth Factor), supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/placental+growth+factor/plgf++placental+growth+factor+/pm32757648-307-13-42
Average 90 stars, based on 1 article reviews
plgf (placental growth factor) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


HPS development in Plgf –/– rats after CBDL and PPVL surgery. (A) Experimental procedures. (B) Circulating PlGF levels in serum determined using ELISA. (C) Detection of Plgf mRNA levels in liver and lung using RT-qPCR. (D) A-aO 2 in arterial blood. (E) Quantification of contrast-enhanced transthoracic echocardiogram: ratio of the difference in acoustic signal between baseline and after injection in the left ventricle to the right ventricle. (F) Quantification of total microspheres in one kidney by fluorescence-activated cell sorting after jugular vein injection. Data are mean ± SEM; comparisons were made using one-way ANOVA followed by the Tukey test: n.s., not significant ( p >0.05); ∗ p <0.05, ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, vs. Sham WT group; &&& p <0.001, &&&& p <0.0001 vs. WT CBDL. A-aO 2 , alveolar–arterial oxygen gradient; CBDL, common bile duct ligation; HPS, hepatopulmonary syndrome; PIGF, placental growth factor; PPVL, partial portal vein ligation; real-time quantitative PCR (RT-qPCR); WT, wild-type.

Journal: JHEP Reports

Article Title: Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome

doi: 10.1016/j.jhepr.2024.101297

Figure Lengend Snippet: HPS development in Plgf –/– rats after CBDL and PPVL surgery. (A) Experimental procedures. (B) Circulating PlGF levels in serum determined using ELISA. (C) Detection of Plgf mRNA levels in liver and lung using RT-qPCR. (D) A-aO 2 in arterial blood. (E) Quantification of contrast-enhanced transthoracic echocardiogram: ratio of the difference in acoustic signal between baseline and after injection in the left ventricle to the right ventricle. (F) Quantification of total microspheres in one kidney by fluorescence-activated cell sorting after jugular vein injection. Data are mean ± SEM; comparisons were made using one-way ANOVA followed by the Tukey test: n.s., not significant ( p >0.05); ∗ p <0.05, ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, vs. Sham WT group; &&& p <0.001, &&&& p <0.0001 vs. WT CBDL. A-aO 2 , alveolar–arterial oxygen gradient; CBDL, common bile duct ligation; HPS, hepatopulmonary syndrome; PIGF, placental growth factor; PPVL, partial portal vein ligation; real-time quantitative PCR (RT-qPCR); WT, wild-type.

Article Snippet: Serum PlGF levels were quantified using an ELISA kit (E-CL-R0520, ElabScience, Houston, Texas, 77079, USA) following the manufacturer’s instructions.

Techniques: Enzyme-linked Immunosorbent Assay, Quantitative RT-PCR, Injection, Fluorescence, FACS, Ligation, Real-time Polymerase Chain Reaction

Cellular origin of upregulated proteins. (A) Transcriptome analysis of the top 30 proteins increased in OC-plasma (from ). (B) Proteome analysis as in (A) . Due to the lower sensitivity of MS-based proteomics, especially for secreted proteins , data were not available for a number of proteins. Boxplots show medians (horizontal line in boxes), upper and lower quartiles (box) and range (whiskers). Arrows point out MUC16, SPINT2, and WFDC2. TU, tumor cells; TAM, tumor-associated macrophage; TAT, tumor-associated T-cells.

Journal: Frontiers in Oncology

Article Title: Multi-platform Affinity Proteomics Identify Proteins Linked to Metastasis and Immune Suppression in Ovarian Cancer Plasma

doi: 10.3389/fonc.2019.01150

Figure Lengend Snippet: Cellular origin of upregulated proteins. (A) Transcriptome analysis of the top 30 proteins increased in OC-plasma (from ). (B) Proteome analysis as in (A) . Due to the lower sensitivity of MS-based proteomics, especially for secreted proteins , data were not available for a number of proteins. Boxplots show medians (horizontal line in boxes), upper and lower quartiles (box) and range (whiskers). Arrows point out MUC16, SPINT2, and WFDC2. TU, tumor cells; TAM, tumor-associated macrophage; TAT, tumor-associated T-cells.

Article Snippet: Other proteins were quantified by ELISA according to the instructions of the respective manufacturer: BCAM (ELH-BCAM-2; BioCat GmbH, Heidelberg, Germany); EPHA2 (ELH-EPHA2-1; RayBiotech Life, Peachtree Corners, GA, USA); GDF15 (DGD150; R&D Systems, Wiesbaden, Germany); IL-6 (Invitrogen-88-7066-22; Thermo Fisher Scientific, Schwerte, Germany); IL-18BP (DBP180; R&D Systems, Wiesbaden, Germany); OPN/SPP1 (DOST00; R&D Systems, Wiesbaden, Germany); SPON1 (CSB-EL022599HU-96; Cusabio, Houston, TX, USA); VEGFA (BMS277-2; Thermo Fisher Scientific, Schwerte, Germany); WFDC2/HE4 (DHE400; R&D Systems, Wiesbaden, Germany); SPINT2 (EK0773-CAP; Boster, Pleasanton, USA); PVRL4/NECTIN4 (DNEC40; R&D Systems, Wiesbaden, Germany).

Techniques: Clinical Proteomics

Association of SPINT2 mRNA expression with survival of OC patients. (A) Kaplan-Meier plot for 1074 HGSC patients in the Kaplan–Meier Plotter database (updated version at http://kmplot.com ) analyzing the association of SPINT2 with RFS. HR, hazard ratio. (B) Kaplan-Meier plot for 1074 HGSC patients in the same database analyzing the association of SPINT2 with OS. (C) z-scores (PRECOG data) for the association of SPINT2 with the overall survival (OS) of the indicated tumor entities . Red: association with a short OS (z-score above +1.5;). Blue: association with a short OS (z-score below −1.5).

Journal: Frontiers in Oncology

Article Title: Multi-platform Affinity Proteomics Identify Proteins Linked to Metastasis and Immune Suppression in Ovarian Cancer Plasma

doi: 10.3389/fonc.2019.01150

Figure Lengend Snippet: Association of SPINT2 mRNA expression with survival of OC patients. (A) Kaplan-Meier plot for 1074 HGSC patients in the Kaplan–Meier Plotter database (updated version at http://kmplot.com ) analyzing the association of SPINT2 with RFS. HR, hazard ratio. (B) Kaplan-Meier plot for 1074 HGSC patients in the same database analyzing the association of SPINT2 with OS. (C) z-scores (PRECOG data) for the association of SPINT2 with the overall survival (OS) of the indicated tumor entities . Red: association with a short OS (z-score above +1.5;). Blue: association with a short OS (z-score below −1.5).

Article Snippet: Other proteins were quantified by ELISA according to the instructions of the respective manufacturer: BCAM (ELH-BCAM-2; BioCat GmbH, Heidelberg, Germany); EPHA2 (ELH-EPHA2-1; RayBiotech Life, Peachtree Corners, GA, USA); GDF15 (DGD150; R&D Systems, Wiesbaden, Germany); IL-6 (Invitrogen-88-7066-22; Thermo Fisher Scientific, Schwerte, Germany); IL-18BP (DBP180; R&D Systems, Wiesbaden, Germany); OPN/SPP1 (DOST00; R&D Systems, Wiesbaden, Germany); SPON1 (CSB-EL022599HU-96; Cusabio, Houston, TX, USA); VEGFA (BMS277-2; Thermo Fisher Scientific, Schwerte, Germany); WFDC2/HE4 (DHE400; R&D Systems, Wiesbaden, Germany); SPINT2 (EK0773-CAP; Boster, Pleasanton, USA); PVRL4/NECTIN4 (DNEC40; R&D Systems, Wiesbaden, Germany).

Techniques: Expressing

Figure 2 NR4A regulation of human endometrial stromal cell (hESC) decidualization in vitro. hESCs were transduced with Ad-LacZ or Ad-NR4A at a multiplicity of infection (MOI) of 25 or were treated with 0.5 mM 8-Br-cAMP and 1 µM MPA for 48 h. PRL (A) and IGFBP1 (B) mRNA levels were measured by real-time PCR. The results are presented as the mean ± SEM; n = 3 samples. * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with Ad-LacZ. hESCs were infected with the indicated adenoviruses at a MOI of 50, followed by treatment with or without 8-Br-cAMP and MPA for an add- itional 4 days. Prolactin (C) and IGFBP-1 (D) released into the medium was measured by Enzyme Linked Fluorescent Assay (ELFA) and ELISA. The results are presented as the mean ± SEM; n = 5 samples. * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with Ad-LacZ. hESCs were transfected with 50 nM of the indicated specific NR4A siRNA for 72 h, followed by treatment with or without 8-Br-cAMP and MPA for an additional 4 days. Prolactin (E) and IGFBP-1 (F) released into the medium were measured by ELFA and ELISA. The results are presented as the mean ± SEM; n = 4 sam- ples. *** P < 0.001 compared with siCTL. # P < 0.05 and ## P < 0.01 compared with siCTL plus 8-Br-cAMP and MPA. (G and H) Fluorescein isothio- cyanate labeled phalloidin was used to label actin filaments, and immunofluorescence was used to analyze the morphological transformation of hESCs.

Journal: Molecular human reproduction

Article Title: Decreased expression of NR4A nuclear receptors in adenomyosis impairs endometrial decidualization.

doi: 10.1093/molehr/gaw042

Figure Lengend Snippet: Figure 2 NR4A regulation of human endometrial stromal cell (hESC) decidualization in vitro. hESCs were transduced with Ad-LacZ or Ad-NR4A at a multiplicity of infection (MOI) of 25 or were treated with 0.5 mM 8-Br-cAMP and 1 µM MPA for 48 h. PRL (A) and IGFBP1 (B) mRNA levels were measured by real-time PCR. The results are presented as the mean ± SEM; n = 3 samples. * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with Ad-LacZ. hESCs were infected with the indicated adenoviruses at a MOI of 50, followed by treatment with or without 8-Br-cAMP and MPA for an add- itional 4 days. Prolactin (C) and IGFBP-1 (D) released into the medium was measured by Enzyme Linked Fluorescent Assay (ELFA) and ELISA. The results are presented as the mean ± SEM; n = 5 samples. * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with Ad-LacZ. hESCs were transfected with 50 nM of the indicated specific NR4A siRNA for 72 h, followed by treatment with or without 8-Br-cAMP and MPA for an additional 4 days. Prolactin (E) and IGFBP-1 (F) released into the medium were measured by ELFA and ELISA. The results are presented as the mean ± SEM; n = 4 sam- ples. *** P < 0.001 compared with siCTL. # P < 0.05 and ## P < 0.01 compared with siCTL plus 8-Br-cAMP and MPA. (G and H) Fluorescein isothio- cyanate labeled phalloidin was used to label actin filaments, and immunofluorescence was used to analyze the morphological transformation of hESCs.

Article Snippet: Detection of prolactin and IGFBP-1 levels in cultured supernatants Prolactin and IGFBP-1 levels in supernatants were measured using a Vidas prolactin kit (bioMérieux) and a human IGFBP1 ELISA kit (BOSTER).

Techniques: In Vitro, Transduction, Infection, Real-time Polymerase Chain Reaction, Fluorescence, Enzyme-linked Immunosorbent Assay, Transfection, Labeling, Transformation Assay